Erin Ross is a member of the Center for Strategic Philanthropy’s biomedical science team, currently leading the Center’s work on Type 1 diabetes screening implementation. In her role, she analyzes the role scientific evidence plays in health policy implementation and identifies ways the scientific and policy communities can collaborate. She has significant experience developing survey classification matrices and coding and has contributed to multiple Milken Institute publications.
With a degree in biochemistry, Ross worked in the life science industry for over 17 years, building strong skills in scientific research, writing, and communication. Her expertise in endotoxin detection assays and primary cell culture contributed to the growth and quality enhancement of multiple product lines during her time in the industry. She is based in the Institute’s Washington, DC office.